Stages of Lymphedema

Stage 0 - Latent / Subclinical

• Lymphatic transport is impaired but no visible swelling is present
• The patient may feel subtle heaviness, tightness, or fullness in the limb
• No pitting, no measurable volume difference on inspection
• Can persist for months to years before progressing to clinical disease
• Detectable only by sensitive methods such as bioimpedance spectroscopy or perometry
• Many researchers debate whether this represents true lymphedema or simply those "at risk" - early intervention at this stage (e.g., compression garment) has been shown to halt progression in over 50% of cases

Stage I - Early / Mild

• Visible accumulation of protein-rich fluid in the interstitium
• Pitting edema: pressing the skin with a thumb leaves a temporary indentation
• Swelling subsides with elevation of the limb (spontaneously reversible)
• Some increase in fibrous connective tissue may be present, but skin and deeper tissues are not permanently damaged
• ISL severity: Minimal (< 20% volume difference)
• Considered reversible - good treatment outcomes expected with Complete Decongestive Therapy (CDT)
• Note: even if swelling resolves, future risk of progressing to Stage II remains elevated

Stage II - Moderate

• Swelling is visible and does NOT subside with elevation alone
• Initially pitting, but over time the tissue undergoes fibrosis and tissue proliferation, making pitting progressively harder to induce and eventually absent
• Active inflammation and scarring of subcutaneous tissues (fibrosis)
• Higher risk of recurrent skin infections (cellulitis, lymphangitis)
• ISL severity: Moderate (20-40% volume difference)
• Tissue damage is not reversible, but with appropriate CDT and good patient compliance, dramatic improvement can be achieved

Stage III - Severe (Lymphostatic Elephantiasis)

• Tissue is markedly fibrotic and hardened; pitting is absent
• Extreme enlargement and distortion of the affected limb
• Characteristic skin changes:
  • Marked skin thickening (hyperkeratosis)
  • Hyperpigmentation
  • Deepened skin folds
  • Fat deposits
  • Warty overgrowths (papillomatosis)
  • Chronic ulceration in advanced cases
• ISL severity: Severe (> 40% volume difference)
• Reduction is still possible with intensive, repeated CDT phases
• In extreme cases, surgical removal of excess skin following conservative therapy may be required

Summary Table (ISL vs Foldi)

Clinical Notes

• Lymphedema most commonly affects a limb after cancer treatment (especially breast cancer after axillary lymph node dissection/radiation), but can also be primary (congenital/idiopathic)
• The Stemmer sign (inability to pinch a fold of skin at the base of the second toe/finger) is a useful clinical indicator - positive in Stage II and beyond
• Early detection and intervention is key: studies show 48% of patients with mild lymphedema progress to a more severe form within 5 years without treatment
• Head and neck lymphedema has separate validated grading scales that also incorporate tissue consistency/palpability